Cited by 166Metabolism, Diabetes, and CancerNatural Antidiabetic Agents StudiesDiet, Metabolism, and Disease

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

Faure, P, Rossini, E, Wiernsperger, N, Richard, M J, Favier, A, Halimi, S·1999·Diabetes

Abstract

Recently there has been growing interest in the effects of antioxidants on insulin activity. In the present study, we investigated the effect of metformin on free radical activity and insulin sensitivity in high fructose-fed rats, a diet that leads to insulin resistance. The animals were divided into four groups (n = 16 per group; experiment duration = 6 weeks): the control (C) group received a standard diet; the control metformin (CM) group was fed a control diet and received metformin (200 mg x kg(-1) x day(-1) in water); the fructose control (FT) group was fed a diet in which fructose composed 56.8% of the total carbohydrates; and the fructose metformin (FM) group received high-fructose diet and metformin (200 mg x kg(-1) x day(-1) in water). The glucose clamp technique was used to determine insulin sensitivity in eight animals per group. Metabolic and oxidative stress parameters were measured in the remaining rats. In the FT rats, insulin resistance, lower red cell CuZn superoxide dismutase activity and lower blood reduced glutathione were observed. Metformin treatment improved both the insulin activity and the antioxidant defense system. In the CM group, metformin had no effect on metabolic parameters, but improved red cell antioxidant enzyme activities and the blood GSH level, which suggests that it has an antioxidant activity independent of its effect on insulin activity.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.2.353

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metformin has recently been reported to have antioxidant effects in addition to known favorable effects on circulating lipids and FFAs.

    “In fact, metformin has recently been reported to have antioxidant effects (34) in addition to the known favorable effects on circulating lipids (10) and FFAs (35).”
  • Metformin reduces reactive oxygen species by inhibiting mitochondrial respiration and decreases advanced glycosylation end product indirectly through reduction of hyperglycemia and directly through an insulin-dependent mechanism.

    “It reduces reactive oxygen species (ROS) by inhibiting mitochondrial respiration [100] and decreases advanced glycosylation end product (AGE) indirectly through reduction of hyperglycemia and directly through an insulin-dependent mechanism [101].”
  • Metformin has been proposed to cause a mild and transient inhibition of mitochondrial complex I which decreases ATP levels and activates AMPK-dependent catabolic pathways, increasing lipolysis and beta-oxidation in white adipose tissue and reducing neoglucogenesis.

    “Metformin has been proposed to cause a mild and transient inhibition of mitochondrial complex I which decreases ATP levels and activates AMPK-dependent catabolic pathways [100], increasing lipolysis and ß-oxidation in white adipose tissue [102] and reducing neoglucogenesis [2].”
  • Metformin can upregulate uncoupled proteins 2 in adipose tissue and can cause an increase in reduced glutathione.

    “It can upregulate uncoupled proteins 2 (UCP2) in adipose tissue [102] and can also cause an increase in reduced glutathione [100].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Faure, P., Rossini, E., Wiernsperger, N., Richard, M. J., Favier, A., & Halimi, S.
Affiliations
Groupe de Recherché sur les Pathologies Oxydatives, UFR de Pharmacie, La Tronche, France. patrice.faure@ujf-grenoble.fr
Venue
Diabetes
Published
1999-02-01
Volume
48
Issue
2
Pages
353-357
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2150046218
Cited by
166
References
14
Citations by year
2026: 1 · 2025: 1 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 11 · 2015: 10 · 2014: 5 · 2013: 10 · 2012: 6
FWCI
2.18
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
metformin, insulin sensitivity, insulin resistance, high-fructose diet, oxidative stress, antioxidant defense, superoxide dismutase, glutathione, free radicals, glucose clamp
MeSH terms
Animals, Dietary Carbohydrates, Fructose, Hypoglycemic Agents, Insulin, Lipid Peroxides, Male, Metformin, Oxidoreductases, Free Radical Scavengers, Rats, Wistar, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review